MARKET

IFRX

IFRX

Inflarx
NASDAQ
0.8949
+0.0695
+8.42%
After Hours: 0.8721 -0.0228 -2.55% 17:24 02/06 EST
OPEN
0.8449
PREV CLOSE
0.8254
HIGH
0.9000
LOW
0.8263
VOLUME
638.60K
TURNOVER
--
52 WEEK HIGH
2.770
52 WEEK LOW
0.7113
MARKET CAP
60.63M
P/E (TTM)
-1.2452
1D
5D
1M
3M
1Y
5Y
1D
Here's Why We're A Bit Worried About InflaRx's (NASDAQ:IFRX) Cash Burn Situation
Simply Wall St · 1d ago
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), InflaRx (IFRX) and Verastem (VSTM)
TipRanks · 3d ago
Weekly Report: what happened at IFRX last week (0126-0130)?
Weekly Report · 5d ago
InflaRx Announces Participation in February Investor Conferences
Barchart · 01/29 06:30
Weekly Report: what happened at IFRX last week (0119-0123)?
Weekly Report · 01/26 09:11
Weekly Report: what happened at IFRX last week (0112-0116)?
Weekly Report · 01/19 09:12
Weekly Report: what happened at IFRX last week (0105-0109)?
Weekly Report · 01/12 09:12
InflaRx Cuts Workforce and Refocuses Strategy on Lead Drug Izicopan to Extend Cash Runway to 2027
TipRanks · 01/08 21:27
More
About IFRX
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.

Webull offers Inflarx NV stock information, including NASDAQ: IFRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IFRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IFRX stock methods without spending real money on the virtual paper trading platform.